Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Trial

被引：0
|
作者：
Pomara, Nunzio [1 ]
Gommoll, Carl [1 ]
Chen, Dalei [1 ]
Nunez, Rene [1 ]
Mathews, Maju [1 ]
Croft, Harry A. [1 ]
机构：
[1] NYU, Sch Med, Nathan Kline Inst, Orangeburg, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2013年 / 38卷
关键词：
vilazodone; major depressive disorder; antidepressant;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T158
引用
收藏
页码：S378 / S379
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Vilazodone in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Croft, Harry A.
    Pomara, Nunzio
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : E1291 - E1298
  • [2] Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
    Mathews, Maju
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Khan, Arif
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) : 67 - 74
  • [3] Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Rickels, Karl
    Athanasiou, Maria
    Robinson, Donald S.
    Gibertini, Michael
    Whalen, Heidi
    Reed, Carol R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 326 - 333
  • [4] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Thase, Michael E.
    Mathews, Maju
    Forero, Giovanna
    Nunez, Rene
    Chen, Changzheng
    Gommoll, Carl
    Durgam, Suresh
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344
  • [5] Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Gommoll, Carl
    Migliore, Raffaele
    Chen, Changzheng
    Chang, Cheng-Tao
    Aguirre, Michelle
    Thase, Michael E.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (06) : 304 - 311
  • [6] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
  • [7] A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
    Suresh Durgam
    Changzheng Chen
    Raffaele Migliore
    Chandran Prakash
    John Edwards
    Robert L. Findling
    [J]. Pediatric Drugs, 2018, 20 : 353 - 363
  • [8] A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
    Durgam, Suresh
    Chen, Changzheng
    Migliore, Raffaele
    Prakash, Chandran
    Edwards, John
    Findling, Robert L.
    [J]. PEDIATRIC DRUGS, 2018, 20 (04) : 353 - 363
  • [9] Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Hoobehfekr, Saba
    Moghaddam, Hossein Sanjari
    Shalbafan, Mohammadreza
    Hashemi, Maryam Ghazizadeh
    Pirmoradi, Mohammad Mehdi
    Sakenian, Amirhossein
    Poopak, Amirhossein
    Kashefinejad, Shayan
    Yarahmadi, Masoomeh
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (02) : 57 - 62
  • [10] Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
    Farajollahi-Moghadam, Mostafa
    Sanjari-Moghaddam, Hossein
    Hasemi, Maryam Ghazizadeh
    Sanatian, Zahra
    Talaei, Ali
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 140 - 146
12345